Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial

  • Gary K. Schwartz
  • , William D. Tap
  • , Li Xuan Qin
  • , Michael B. Livingston
  • , Samir D. Undevia
  • , Bartosz Chmielowski
  • , Mark Agulnik
  • , Scott M. Schuetze
  • , Damon R. Reed
  • , Scott H. Okuno
  • , Joseph A. Ludwig
  • , Vicki Keedy
  • , Petra Rietschel
  • , Andrew S. Kraft
  • , Douglas Adkins
  • , Brian A. Van Tine
  • , Bruce Brockstein
  • , Vincent Yim
  • , Christiana Bitas
  • , Abdul Abdullah
  • Cristina R. Antonescu, Mercedes Condy, Mark A. Dickson, Shyamprasad Deraje Vasudeva, Alan L. Ho, L. Austin Doyle, Helen X. Chen, Robert G. Maki

Research output: Contribution to journalArticlepeer-review

179 Scopus citations

Fingerprint

Dive into the research topics of 'Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: A multicentre, open-label, phase 2 trial'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry